← Back to all signals
RESEARCH PAPER ANALYSIS

Cerebral Cavernous Malformations and Focal Drug-Resistant Epilepsy: Behind a Quid Pro Quo of Lesion and Epileptogenic Networks.

AI interpretation is pending for this paper.

Open original publication →
PMID40590677
JournalEuropean journal of neurology
Publication Date2025-07-01
Ingested2026-08-02 12:04 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Cerebral cavernous malformations (CCMs) contribute to focal drug-resistant epilepsy (fDRE), with surgical outcomes varying due to an incomplete understanding of the interplay between CCM-impacted regions and areas exhibiting ictal or interictal epileptogenicity. This study quantified the epileptogenicity of brain structures sampled by stereo-electroencephalography (SEEG) electrodes in patients with fDRE and supratentorial CCMs, focusing on the irritative zone (IZN) and epileptogenic-zone network (EZN). It also established a framework for describing EZN organization relative to CCM-affected regions. METHODS: Retrospective multicentric cohort study involving fDRE patients with supratentorial CCMs, explored using SEEG, recruited from five French tertiary epilepsy centers. SEEG-sampled brain regions were classified as lesional, perilesional, or non-lesion-associated according to their anatomic relationship with the CCMs and using the Virtual Epileptic Patient brain atlas parcellation. IZN quantification was performed using spike rates per minute. EZN was evaluated using the Epileptogenicity Index or Permutation Entropy Index according to the seizure-onset pattern. Data were analyzed using both descriptive and inferential statistics. RESULTS: The study included 22 patients, 10 of whom underwent post-SEEG epilepsy surgery. IZN biomarkers differed significantly between lesional, perilesional, and non-lesion-associated areas, whereas EZN biomarkers did not. EZN included lesional areas in 50% of cases, with complex multi-lobar networks identified in most patients. Postsurgical seizure freedom was achieved in 70% of SEEG-explored patients. CONCLUSIONS: Our findings highlight the complex relationship between CCMs and the EZN, supporting SEEG in the presurgical work-up of selected patients with CCMs and fDRE. A network-based surgical approach may improve outcomes by tailoring resections to the EZN.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Maternal smoking and risk of childhood cancer: a report from the Childhood Cancer and Leukemia International Consortium. International journal of epidemiology 64.0 2 Profile of Invasive Fungal Infections in a Paediatric Haemato-Oncology Unit: A Five-Year Retrospective Cohort Study From a Tertiary Care Centre in South India. Cureus 70.8 3 Prevalence and risk factors of persistent and neuropathic pain following resection of pediatric extremity soft tissue sarcomas: A nationwide cohort study. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 69.4 4 Neonatal airway emergency: congenital laryngeal myxoma. Journal of surgical case reports 47.9 5 Burkitt Lymphoma Presenting as Renal Failure: Learning From Diagnostic Pitfalls in Pediatrics. Clinical case reports 51.5 6 Reference frame for Adult Brainstem gliomas. The oncologist 68.2 7 Pharmacogenomics of cancer therapy-related cardiomyopathy in childhood cancer survivors. Pharmacogenomics 68.44 8 HPV Vaccination Uptake Among Children Attending Polish Primary Schools and Parental Factors Influencing Vaccination: A Cross-sectional Study. Journal of community health 59.0 9 Social Media and HPV Vaccine Hesitancy: How Misinformation Affects Latino Parents. Journal of community health 63.2 10 Overcoming Primary Graft Failure in Pediatric Allogeneic HSCT: Insights from Ten Centers of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC). Transplantation and cellular therapy 61.94 11 Beyond the Favorable-Risk Label: Sequential Measurable Residual Disease and KIT Variant Status in Pediatric Core-Binding Factor Acute Myeloid Leukemia. Annals of laboratory medicine 47.5 12 Incidence rates of non-Hodgkin lymphoma subtypes among Black Africans with and without HIV in South Africa: a national registry-based study. The Lancet regional health. Africa 67.9 13 Primary extranodal marginal zone lymphoma of gastric mucosa-associated lymphoid tissue in children: a case report and review of the literature. Journal of medical case reports 57.4 14 Neurofibromatosis Type 1: An Imaging Review of Multisystem Manifestations in Children. Journal of neuroimaging : official journal of the American Society of Neuroimaging 58.4 15 Reconstructive Strategies for Abdominal Wall Defects in Patients With Stomas: A Systematic Review of Mesh and Flap Techniques. Cureus 74.5 16 Landscape of cancer genomics and precision oncology in Japan, South Korea, China, and Australia. The Lancet regional health. Western Pacific 57.0 17 Deep learning segmentation of the cerebral ventricular system and brainstem for pediatric radiotherapy planning. Physics and imaging in radiation oncology 71.94 18 Real-world clinical outcomes and safety of anlotinib-containing regimens in pediatric solid tumors: a retrospective cohort study at a Chinese center. Frontiers in oncology 72.2 19 Regression of severe sclerotic chronic graft-versus-host disease after a second haploidentical hematopoietic stem cell transplantation: a case report. Frontiers in medicine 62.2 20 Editorial: Advances in the diagnosis and treatment of pediatric hematological disorders. Frontiers in pediatrics 50.74 21 Disability pension receipt five years after cancer diagnosis: a matched registry study of working-age cancer survivors in Norway. Frontiers in health services 64.0 22 Early discontinuation vs. continuation of empirical antibiotics in patients with cancer and febrile neutropenia: a systematic review and meta-analysis of randomized controlled trials. Frontiers in microbiology 82.0 23 Novel juxtamembrane FLT3 in-frame insertion in a child with refractory AML: a case report of durable remission following allogeneic HSCT and FLT3 inhibitor therapy. Frontiers in oncology 64.48 24 Case Report: Pallister-Hall syndrome diagnosed in adulthood during evaluation of recurrent hypoglycemia. Frontiers in endocrinology 49.0 25 Efficacy and safety of immunotherapy in pediatric malignant brain tumors: a systematic review and exploratory meta-analysis. Frontiers in oncology 84.42 26 Case Report: DICER1 mutation-associated anaplastic sarcoma of the kidney in a child. Frontiers in oncology 49.9 27 Epstein-Barr virus and hepatic failure: pathogenesis, clinical manifestations, and management. Frontiers in immunology 62.0 28 Fibrous hamartoma of infancy: a case report. Frontiers in pediatrics 49.9 29 ST6Gal2 promotes α2,6-sialylation and aggressive phenotypes in neuroblastoma cells. bioRxiv : the preprint server for biology 66.8 30 Prevalence and genotype distribution of human papillomavirus (HPV) among adolescent girls and young women in a high HIV burden rural area of South Africa: a cross-sectional survey. Research square 61.0 31 Language of Hope in Conversations between Pediatric Oncologists, Children with Advanced Cancer, and their Families. Research square 57.6 32 Fifteen-year surveillance of non-typhoidal Salmonella bloodstream infections in a tertiary care hospital in southern Türkiye. Journal of infection in developing countries 67.0
PATIENT-FRIENDLY SUMMARY

Cerebral Cavernous Malformations and Focal Drug-Resistant Epilepsy: Behind a Quid Pro Quo of Lesion and Epileptogenic Networks.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic